BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 26399266)

  • 1. Left Atrial Thrombus Associated With Interatrial Septal Occluder 5 Years After Implantation.
    Misra S; Conte J; Resar J
    Circ Cardiovasc Interv; 2015 Oct; 8(10):e002856. PubMed ID: 26399266
    [No Abstract]   [Full Text] [Related]  

  • 2. Stepwise Progression of Right-to-Left Atrial Shunting through a Combination of Patent Foramen Ovale and Tricuspid Regurgitation.
    Kransdorf EP; Kransdorf LN; Fortuin FD; Sweeney JP; Wilansky S
    Tex Heart Inst J; 2016 Apr; 43(2):171-4. PubMed ID: 27127438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac magnetic resonance imaging and the WATCHMAN device.
    Hong SN; Rahimi A; Kissinger KV; Pedrosa I; Manning WJ; O'Halloran TD
    J Am Coll Cardiol; 2010 Jun; 55(24):2785. PubMed ID: 20538174
    [No Abstract]   [Full Text] [Related]  

  • 4. Device-Associated Left Atrial Thrombosis Despite Oral Anticoagulation After Percutaneous Patent Foramen Ovale Closure.
    Tzimas G; Muller O; Kirsch M; Monney P
    Can J Cardiol; 2019 Nov; 35(11):1605.e5-1605.e6. PubMed ID: 31679631
    [No Abstract]   [Full Text] [Related]  

  • 5. Amplatzer occluder versus CardioSEAL/STARFlex occluder: a meta-analysis of the efficacy and safety of transcatheter occlusion for patent foramen ovale and atrial septal defect.
    Li Y; Zhou K; Hua Y; Wang C; Xie L; Fang J; Rong X; Shen J
    Cardiol Young; 2013 Aug; 23(4):582-96. PubMed ID: 23199453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late left atrial thrombosis of an Amplatzer patent foramen ovale occluder.
    Klotz S; Gebhard M; Sievers HH
    J Thorac Cardiovasc Surg; 2011 Nov; 142(5):1270-1. PubMed ID: 21724200
    [No Abstract]   [Full Text] [Related]  

  • 7. Results of percutaneous closure of patent foramen ovale with the GORE(®) septal occluder.
    Knerr M; Bertog S; Vaskelyte L; Hofmann I; Sievert H
    Catheter Cardiovasc Interv; 2014 Jun; 83(7):1144-51. PubMed ID: 24323667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unexpected perforation leading to life-threatening cardiac tamponade six years after patent foramen ovale closure with an intrasept device.
    Vandeloo B; Dymarkowski S; Budts W
    Acta Cardiol; 2016 Apr; 71(2):247-8. PubMed ID: 27090049
    [No Abstract]   [Full Text] [Related]  

  • 9. Pacemaker lead entrapment complicating transcatheter closure of a patent foramen ovale.
    Quevedo HC; Arain SA; Abi Rafeh N
    JACC Cardiovasc Interv; 2014 Nov; 7(11):e171-2. PubMed ID: 25459047
    [No Abstract]   [Full Text] [Related]  

  • 10. Thrombus formation 4 years after percutaneous transcatheter closure of an atrial septal defect.
    Furuta A; Nagashima M; Sugiyama H; Sakamoto T; Yamazaki K
    J Card Surg; 2017 Aug; 32(8):492-493. PubMed ID: 28743158
    [No Abstract]   [Full Text] [Related]  

  • 11. Subacute endocarditis of an atrial septal closure device in a patient with a patent foramen ovale.
    Krantz SB; Lawton JS
    Ann Thorac Surg; 2014 Nov; 98(5):1821-3. PubMed ID: 25441794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombus formation on the Amplatzer device: a need for critical attitude in percutaneous patent ovale closure decision-making.
    Ciurus T; Piestrzeniewicz K; Maciejewski M; Łuczak K; Jakubowski P; Drożdż J
    Eur Heart J; 2015 May; 36(19):1195. PubMed ID: 25433024
    [No Abstract]   [Full Text] [Related]  

  • 13. Three-dimensional transesophageal echocardiography of a thrombus entrapped by a patent foramen ovale.
    Sattiraju S; Masri SC; Liao K; Missov E
    Ann Thorac Surg; 2012 Oct; 94(4):e101-2. PubMed ID: 23006715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel approach to successful removal of right atrial thrombus during percutaneous patent foramen ovale closure.
    Prasad S; Meredith I; Harper RW
    Int J Cardiol; 2010 Jun; 142(1):e8-10. PubMed ID: 19150576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quest for the ideal ASD/PFO closure device continues.
    Balaguru D; Rao PS
    J Invasive Cardiol; 2010 Apr; 22(4):188-9. PubMed ID: 20351391
    [No Abstract]   [Full Text] [Related]  

  • 16. Foreign body granuloma as an unexpected long-term finding after percutaneous closure of a patent foramen ovale.
    Besler C; Bakhtiary F; Linke A; Zimmer M
    Eur Heart J; 2017 Dec; 38(46):3472-3473. PubMed ID: 28369276
    [No Abstract]   [Full Text] [Related]  

  • 17. Serpentine thrombus in the heart: a rare case of trapped thrombus in patent foramen ovale.
    Zoltowska DM; Agrawal Y; Kalavakunta JK
    BMJ Case Rep; 2018 Mar; 2018():. PubMed ID: 29563129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late left atrial thrombosis of an Amplatzer patent foramen ovale occluder may be the result of Kounis hypersensitivity-associated syndrome.
    Kounis NG; Soufras GD; Mazarakis A
    J Thorac Cardiovasc Surg; 2012 Jul; 144(1):276; author reply 276-7. PubMed ID: 22710041
    [No Abstract]   [Full Text] [Related]  

  • 19. Percutaneous removal of unraveled HELEX® septal occluder 4 months post deployment.
    Suntharos P; Komarlu R; Prieto LR
    Catheter Cardiovasc Interv; 2015 Jul; 86(1):115-20. PubMed ID: 25639512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulomatous mass adherent to a patent foramen ovale occluder.
    Ancedy Y; Bernard Brunet A; Quilliet L; Mirza A; Fauchier L
    Eur Heart J; 2013 Aug; 34(29):2251. PubMed ID: 23704707
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.